| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/02/1997 | EP0770680A2 Lymphocyte-associated cell surface protein |
| 05/02/1997 | EP0770679A2 HCV-specific peptides, preparations related to them and their use |
| 05/02/1997 | EP0770677A2 Improved sustainable chicken cell line for the production of Marek's disease vaccines |
| 05/02/1997 | EP0770627A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 05/02/1997 | EP0770626A2 Method for purifying thrombomodulin |
| 05/02/1997 | EP0770625A2 Process for the purification of Factor VII and activated Factor VII |
| 05/02/1997 | EP0770624A2 Peptide capable of inducing immune response to human gastric cancer and agent containing it for preventing or treating human gastric cancer |
| 05/02/1997 | EP0770623A1 Novel calcitonin derivatives |
| 05/02/1997 | EP0770398A2 Pharmaceutical composition comprising a lens antigen for treatment of cataract |
| 05/02/1997 | EP0770397A1 Newcastle disease virus combination vaccine |
| 05/02/1997 | EP0770396A2 Use of new factor VIII coagulant polypeptides |
| 05/02/1997 | EP0770395A1 Use of botulinum toxins for treating headache |
| 05/02/1997 | EP0770143A1 Method to identify tumor suppressor genes |
| 05/02/1997 | EP0770138A2 Mycobacteria functional screening and/or expression vectors |
| 05/02/1997 | EP0770137A1 Improvements in production of proteins in host cells |
| 05/02/1997 | EP0770136A1 Method for selecting high-expressing host cells |
| 05/02/1997 | EP0770135A1 Novel compounds |
| 05/02/1997 | EP0770131A1 Immunodominant polypeptides |
| 05/02/1997 | EP0770130A1 METHOD FOR IDENTIFYING NUCLEIC ACIDS ENCODING c-fos PROMOTER ACTIVATING PROTEINS |
| 05/02/1997 | EP0770129A1 Zinc finger protein derivatives and methods therefor |
| 05/02/1997 | EP0770128A1 Ikaros transgenic cells and animals |
| 05/02/1997 | EP0770127A1 Stem cell immobilisation |
| 05/02/1997 | EP0770094A1 Modified g-protein coupled receptors |
| 05/02/1997 | EP0770093A1 Proteins from mammalian liver and their use in oncology |
| 05/02/1997 | EP0770092A1 $i(HELICOBACTER PYLORI) NICKEL BINDING PROTEIN |
| 05/02/1997 | EP0770090A1 Epstein-barr virus nuclear antigen 1 protein and its expression and recovery |
| 05/02/1997 | EP0770089A1 Growth differentiation factor-12 |
| 05/02/1997 | EP0770088A1 Novel cytokine designated lerk-5 |
| 05/02/1997 | EP0770086A1 Macrophage migration inhibitory factor-3 |
| 05/02/1997 | EP0769958A1 Inhibitors of leukocyte adhesion |
| 05/02/1997 | EP0769956A1 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| 05/02/1997 | EP0769955A1 Non-antigenic amine derived polymers and polymer conjugates |
| 05/02/1997 | EP0769952A1 Chicken infectious anemia virus vaccine |
| 05/02/1997 | EP0627006B1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin |
| 05/02/1997 | EP0594594B1 Methods of producing hybrid g protein-coupled receptors |
| 05/02/1997 | EP0500917B1 Recombinant herpes simplex viruses vaccines and methods |
| 05/02/1997 | EP0328552B2 Thrombin derived polypeptides, compositions and methods for use |
| 05/01/1997 | WO1997015830A1 A method for detecting a mammal's prior exposure to radiation or radiomimetic chemicals |
| 05/01/1997 | WO1997015686A1 Diagnosis of susceptibility to cancer and treatment thereof |
| 05/01/1997 | WO1997015679A1 Recombinant viruses containing mobile genetic elements and methods of use in gene therapy |
| 05/01/1997 | WO1997015677A2 New strains of bacillus thuringiensis and pesticide composition containing them |
| 05/01/1997 | WO1997015672A1 Dna containing novel gene |
| 05/01/1997 | WO1997015671A1 Luminal cholecystokinin-releasing factor |
| 05/01/1997 | WO1997015670A1 Novel subtilisin inhibitors |
| 05/01/1997 | WO1997015669A1 Chimeric receptor genes and cells transformed therewith |
| 05/01/1997 | WO1997015668A2 Methods and compositions comprising glut-2 and glut-2 chimeras |
| 05/01/1997 | WO1997015667A1 Biologically active eph family ligands |
| 05/01/1997 | WO1997015666A1 Therapeutic antiangiogenic compositions and methods |
| 05/01/1997 | WO1997015665A1 Heterotetrameric coiled coil structures |
| 05/01/1997 | WO1997015664A1 Intensive homologous promoter obtained from hamsters |
| 05/01/1997 | WO1997015663A1 A novel haemopoietin receptor and genetic sequences encoding same |
| 05/01/1997 | WO1997015659A1 Crystalline frap complex |
| 05/01/1997 | WO1997015600A1 Tick (ixodes scapularis) vector saliva-induced lyme disease spirochete (borrelia burgdorferi) antigens as vaccine candidates |
| 05/01/1997 | WO1997015599A1 Novel acetaldehyde and malondialdehyde protein adducts as markers for alcohol liver disease |
| 05/01/1997 | WO1997015598A1 Novel peptide |
| 05/01/1997 | WO1997015597A1 HUMAN EPITHELIAL ANTIGEN Ep-CAM DERIVED PEPTIDES AND THEIR USE |
| 05/01/1997 | WO1997015596A1 Human pec-60-like protein and dna encoding the same |
| 05/01/1997 | WO1997015595A1 Method of mobilizing hematopoietic stem cells |
| 05/01/1997 | WO1997015594A1 Novel chemokine for mobilizing stem cells |
| 05/01/1997 | WO1997015593A1 Neurotrophin antagonists |
| 05/01/1997 | WO1997015592A1 Novel human cysteine protease |
| 05/01/1997 | WO1997015591A1 Hemoglobin mutants that reduce heme loss |
| 05/01/1997 | WO1997015590A1 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application |
| 05/01/1997 | WO1997015589A1 Alpha-helix mimetics and methods relating thereto |
| 05/01/1997 | WO1997015587A1 Abl-interactor protein |
| 05/01/1997 | WO1997015586A1 Rip: novel human protein involved in tumor necrosis factor signal transduction, and screening assays |
| 05/01/1997 | WO1997015391A1 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
| 05/01/1997 | WO1997015330A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
| 05/01/1997 | WO1997015326A1 Remedy for hepatitides |
| 05/01/1997 | WO1997015325A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 05/01/1997 | WO1997015322A1 Methods for restoring or enhancing reproductive function in reproductively impaired hosts |
| 05/01/1997 | WO1997015320A1 Novel uses of mammalian ctla-8 and related reagents |
| 05/01/1997 | WO1997015318A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | WO1997015317A1 GnRH/REDUCED PSEUDOMONAS EXOTOXIN CONJUGATES |
| 05/01/1997 | WO1997015310A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 05/01/1997 | WO1997015195A1 Hybrid matrix implants and explants |
| 05/01/1997 | WO1997001647A3 Dna sequences for identifying highly transmissible lineages of pseudomonas (burkholderia) cepacia |
| 05/01/1997 | WO1996040925A3 Regulatory elements conferring tapetum specificity |
| 05/01/1997 | CA2238940A1 Luminal cholecystokinin-releasing factor |
| 05/01/1997 | CA2235767A1 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
| 05/01/1997 | CA2235756A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | CA2235685A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization |
| 05/01/1997 | CA2235575A1 Novel human cysteine protease |
| 05/01/1997 | CA2235510A1 Gnrh/reduced pseudomonas exotoxin conjugates |
| 05/01/1997 | CA2235509A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 05/01/1997 | CA2235360A1 Novel chemokine for mobilizing stem cells |
| 05/01/1997 | CA2233882A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines |
| 05/01/1997 | CA2233248A1 New strains of bacillus thuringiensis and pesticide composition containing them |
| 05/01/1997 | CA2232241A1 Diagnosis of susceptibility to cancer and treatment thereof |
| 05/01/1997 | CA2231245A1 Hemoglobin mutants that reduce heme loss |
| 05/01/1997 | CA2229426A1 Crystalline frap complex |
| 05/01/1997 | CA2207846A1 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application |
| 05/01/1997 | CA2204906A1 Neurotrophin antagonists |
| 04/30/1997 | DE19613606C1 Gene for hypertension present on chromosome 12p |
| 04/30/1997 | DE19539493A1 Starker homologer Promotor aus Hamster Powerful homologous promoter from hamsters |
| 04/30/1997 | CN1148626A Method for secretory generation of protein |
| 04/30/1997 | CN1034733C Spiro piperidines and homologs which promote release of growth hormone |
| 04/29/1997 | US5625136 Synthetic DNA sequence having enhanced insecticidal activity in maize |
| 04/29/1997 | US5625126 Transgenic non-human animals for producing heterologous antibodies |
| 04/29/1997 | US5625121 Mice deficient in nerve growth factor receptors encoded by trkB |